Development of New Amide Derivatives of Betulinic Acid: Synthetic Approaches and Structural Characterization
Year: 2025
Type: article
Abstract: In this study, we report the synthesis of three new derivatives of betulinic acid, a pentacyclic triterpenoid known for its antitumor activity. These derivatives were synthesized via amide bond formation at the C-28 position using 3-[(Ethylimino)methylidene]amino-N,N-dimethylpropan-1-amine (EDC)/Hydroxybenzotriazole (HOBt) activation and various amines as nucleophiles. The synthesized compounds were characterized by nuclear magnetic resonance (NMR) techniques, including proton (1H), carbon-13 (13C), COSY, HSQC, and DEPT, as well as ultraviolet–visible (UV-VIS) spectroscopy, Fourier-transform infrared (IR) and elemental analysis. This work highlights the potential of semi-synthetic modification of betulinic acid to enhance anticancer properties while addressing challenges in solubility and bioavailability. Further structural optimization and formulation studies are warranted to improve drug-like properties and therapeutic applicability.
Source: Molbank
DOI: 10.3390/m2072
Authors: Qinwei Xu, Yuhan Xie, Jin Qi, Zimo Ren, Carmine Coluccini, Paolo Coghi
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $603
Awards: G3413154885, G4242760534, G6594299004, Development of Online Peptide/Phosphorylated Peptide Base-Reverse Phase Fractionation Chromatography-Ms, Antibody/Protein Plate and Metabolomics Platform for the Discovery, Rapid Diagnosis and Herbal Inhibitor Screening of Clinical Biomarkers( III ), Incorporation of Organic Switches in Hollow Shaped Molecules for Drug Recognition, Delivering and Release
OpenAlex ID: W4415369839
